Drug intelligence / Profile preview

Viruela Tipo Pollo Plus

Development stage: Unknown
Lead developer: FARVET
Modality: Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration: Wing-web Puncture

Overview

Viruela Tipo Pollo Plus is a live attenuated lyophilized vaccine developed by FARVET for the prevention of fowlpox in poultry. The vaccine contains a modified strain of the fowlpox virus that induces active immunity without causing the full disease. It is typically administered via the wing-web (wing puncture) method. The 'Plus' designation refers to a specific high-titer or stabilized formulation intended for robust protection in commercial poultry operations. It is approved for use in several Latin American markets where FARVET operates.

Brand names: Viruela Tipo Pollo Plus
Other names: Vacuna contra la Viruela Aviar PlusFowlpox virus vaccine

Beyond the preview

Go deeper on Viruela Tipo Pollo Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viruela Tipo Pollo Plus.

Explore the full profile